Balinatunfib

DRUG3 trials

Sponsors

Sanofi-Aventis Recherche & Developpement, Sanofi

Conditions

Cardiac RepolarizationColitis UlcerativeCrohn's DiseaseCrohn's diseaseHealthy Volunteers

Phase 1

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

CompletedNCT07272629

SanofiCardiac Repolarization, Healthy Volunteers

Start: 2025-12-04End: 2026-06-08Updated: 2026-06-23

Phase 2

A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)

Active, not recruitingNCT07222189

SanofiColitis Ulcerative, Crohn's Disease

Start: 2026-05-19End: 2026-10-14Target: 325Updated: 2026-09-15

A multinational, multicenter extension study to investigate the long-term safety, tolerability and efficacy of balinatunfib in adults with Crohn’s disease or ulcerative colitis

Not yet recruitingCTIS2025-522511-42-00

Sanofi-Aventis Recherche & DeveloppementColitis Ulcerative, Crohn's disease

Target: 2Updated: 2026-03-06